Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
Is a |
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form) |
true |
Inferred relationship |
Some |
|
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
Has manufactured dose form |
Oral tablet |
true |
Inferred relationship |
Some |
|
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Ivacaftor (substance) |
true |
Inferred relationship |
Some |
1 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Ivacaftor (substance) |
true |
Inferred relationship |
Some |
1 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Tezacaftor (substance) |
true |
Inferred relationship |
Some |
2 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Tezacaftor (substance) |
true |
Inferred relationship |
Some |
2 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Elexacaftor |
true |
Inferred relationship |
Some |
3 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Elexacaftor |
true |
Inferred relationship |
Some |
3 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
3 |
|
Elexacaftor 100 mg and ivacaftor 75 mg and tezacaftor 50 mg oral tablet |
This attribute specifies the denominator unit for the presentation strength of a product. |
Tablet (unit of presentation) |
true |
Inferred relationship |
Some |
3 |
|